Your browser doesn't support javascript.
loading
Phosphofructokinases Axis Controls Glucose-Dependent mTORC1 Activation Driven by E2F1.
Almacellas, Eugènia; Pelletier, Joffrey; Manzano, Anna; Gentilella, Antonio; Ambrosio, Santiago; Mauvezin, Caroline; Tauler, Albert.
Afiliação
  • Almacellas E; Department of Biochemistry and Physiology, School of Pharmacy, University of Barcelona, Barcelona, Catalonia 08028, Spain; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital
  • Pelletier J; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08908, Spain.
  • Manzano A; Biochemistry Unit, Physiological Sciences Department, Faculty of Medicine and Health Science, University of Barcelona (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08907, Spain.
  • Gentilella A; Department of Biochemistry and Physiology, School of Pharmacy, University of Barcelona, Barcelona, Catalonia 08028, Spain; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital
  • Ambrosio S; Biochemistry Unit, Physiological Sciences Department, Faculty of Medicine and Health Science, University of Barcelona (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08907, Spain.
  • Mauvezin C; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet del Llobregat, Barcelona, Catalonia 08908, Spain. Electronic address: cmauvezin@idibell.cat.
  • Tauler A; Department of Biochemistry and Physiology, School of Pharmacy, University of Barcelona, Barcelona, Catalonia 08028, Spain; Laboratory of Cancer Metabolism, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital
iScience ; 20: 434-448, 2019 Oct 25.
Article em En | MEDLINE | ID: mdl-31627130
ABSTRACT
Cancer cells rely on mTORC1 activity to coordinate mitogenic signaling with nutrients availability for growth. Based on the metabolic function of E2F1, we hypothesize that glucose catabolism driven by E2F1 could participate on mTORC1 activation. Here, we demonstrate that glucose potentiates E2F1-induced mTORC1 activation by promoting mTORC1 translocation to lysosomes, a process that occurs independently of AMPK activation. We showed that E2F1 regulates glucose metabolism by increasing aerobic glycolysis and identified the PFKFB3 regulatory enzyme as an E2F1-regulated gene important for mTORC1 activation. Furthermore, PFKFB3 and PFK1 were found associated to lysosomes and we demonstrated that modulation of PFKFB3 activity, either by substrate accessibility or expression, regulates the translocation of mTORC1 to lysosomes by direct interaction with Rag B and subsequent mTORC1 activity. Our results support a model whereby a glycolytic metabolon containing phosphofructokinases transiently interacts with the lysosome acting as a sensor platform for glucose catabolism toward mTORC1 activity.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article